137 related articles for article (PubMed ID: 38159467)
1. Progestin-primed ovarian stimulation: for whom, when and how?
Ata B; Kalafat E
Reprod Biomed Online; 2024 Feb; 48(2):103639. PubMed ID: 38159467
[TBL] [Abstract][Full Text] [Related]
2. Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF.
Pai AH; Sung YJ; Li CJ; Lin CY; Chang CL
Reprod Biol Endocrinol; 2023 Aug; 21(1):72. PubMed ID: 37550681
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles.
Zhou R; Dong M; Huang L; Wang S; Wang Z; Xu L; Zhang X; Liu F
J Clin Endocrinol Metab; 2023 Dec; 109(1):217-226. PubMed ID: 37450562
[TBL] [Abstract][Full Text] [Related]
4. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses.
Ata B; Capuzzo M; Turkgeldi E; Yildiz S; La Marca A
Hum Reprod Update; 2021 Jan; 27(1):48-66. PubMed ID: 33016316
[TBL] [Abstract][Full Text] [Related]
5. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
Xiao ZN; Peng JL; Yang J; Xu WM
Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the cumulative live birth rates after 1 in vitro fertilization cycle in women using gonadotropin-releasing hormone antagonist protocol vs. progestin-primed ovarian stimulation: a propensity score-matched study.
Chen H; Teng XM; Sun ZL; Yao D; Wang Z; Chen ZQ
Fertil Steril; 2022 Oct; 118(4):701-712. PubMed ID: 35940929
[TBL] [Abstract][Full Text] [Related]
7. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis.
Du M; Zhang J; Li Z; Liu X; Li J; Liu W; Guan Y
Front Endocrinol (Lausanne); 2021; 12():705264. PubMed ID: 34589055
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing
Yang L; Liang F; Yuan Y; Luo X; Wang Q; Yao L; Zhang X
Front Endocrinol (Lausanne); 2023; 14():1224858. PubMed ID: 37795363
[TBL] [Abstract][Full Text] [Related]
10. Progestin-primed ovarian stimulation is a feasible method for poor ovarian responders undergoing in IVF/ICSI compared to a GnRH antagonist protocol: A retrospective study.
Huang P; Tang M; Qin A
J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):99-102. PubMed ID: 30321608
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cumulative live birth rates between progestin-primed ovarian stimulation protocol and gonadotropin-releasing hormone antagonist protocol in different populations.
Zhou R; Dong M; Huang L; Wang S; Fan L; Liang X; Zhang X; Liu F
Front Endocrinol (Lausanne); 2023; 14():1117513. PubMed ID: 37143731
[TBL] [Abstract][Full Text] [Related]
12. Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function.
Xu S; Wang X; Zhang Y; Han Y; Zhang C
Gynecol Endocrinol; 2023 Dec; 39(1):2217263. PubMed ID: 37236243
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.
Zhang S; Yin Y; Li Q; Zhang C
Front Endocrinol (Lausanne); 2021; 12():644456. PubMed ID: 34234739
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the pregnancy outcomes of progestin-primed vs. antagonist ovarian stimulation in patients with poor ovarian response: a retrospective study.
Shi Z; Zhao W; Wu X; Bi X
Gynecol Endocrinol; 2024 May; 40(1):2352133. PubMed ID: 38749017
[TBL] [Abstract][Full Text] [Related]
15. Progestins versus GnRH analogues for pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and meta-analysis.
Alexandru P; Cekic SG; Yildiz S; Turkgeldi E; Ata B
Reprod Biomed Online; 2020 Jun; 40(6):894-903. PubMed ID: 32327297
[TBL] [Abstract][Full Text] [Related]
16. Comparison of neonatal outcomes and live-birth defects after progestin-primed ovarian stimulation versus conventional ovarian stimulation for in vitro fertilization: A large retrospective cohort study.
Wang N; Lin J; Zhu Q; Fan Y; Wang Y; Fu Y; Kuang Y
Medicine (Baltimore); 2018 Aug; 97(34):e11906. PubMed ID: 30142796
[TBL] [Abstract][Full Text] [Related]
17. Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma.
Yang AM; Feng TF; Han Y; Zhao ZM; Wang W; Wang YZ; Zuo XQ; Xu X; Shi BJ; Li L; Hao GM; Cui N
Front Endocrinol (Lausanne); 2022; 13():798434. PubMed ID: 35574014
[TBL] [Abstract][Full Text] [Related]
18. Cumulative live birth rate of in vitro fertilization cycle via progestin-primed ovarian stimulation versus gonadotropin-releasing hormone antagonist protocol in infertile women with normal ovarian reserve: an open-label, randomized controlled trial.
Ye H; Shi L; Quan X; Hou M; Ma H; Xue S; Yu Z; Chen Q; Sun L
Hum Fertil (Camb); 2024 Dec; 27(1):2316005. PubMed ID: 38357937
[TBL] [Abstract][Full Text] [Related]
19. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
20. Role and effectiveness of progestins in pituitary suppression during ovarian stimulation for assisted reproductive technology: a systematic review and a meta-analysis.
Yildiz S; Turkgeldi E; Ata B
Minerva Obstet Gynecol; 2023 Dec; 75(6):573-582. PubMed ID: 36193835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
